The target antigens mainly include Hu, Yo, NMDAR, etc. [4–6] The clinical syndromes consist of autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS). This evidence concerns the gene CDR2 and paraneoplastic neurologic syndrome.